文献速递血管炎

超越症状:通过多维患者报告结局测量实现巨细胞动脉炎的个体化诊疗

Beyond the symptoms: Personalizing giant cell arteritis care through multidimensional patient reported outcome measure.
PubMed 文献 · Semin Arthritis Rheum · 2023-10-28

本研究基于OMERACT大血管炎核心结局框架和FDA指南原则,开发并验证了巨细胞动脉炎患者自报结局问卷(GCA-PROMs)。54例GCA患者完成问卷,标准化α信度0.878-0.983,功能残疾与生活质量与HAQ和EQ-5D显著相关(p<0.01),且随疾病活动状态和治疗反应显著变化(p<0.01)。

要点

  • GCA-PROMs问卷在54例巨细胞动脉炎患者中显示出高内部一致性信度(标准化α 0.878-0.983)。
  • GCA-PROMs的功能残疾和生活质量评估与HAQ及EQ-5D显著相关(p<0.01)。
  • 功能残疾和生活质量的变化随疾病活动状态及治疗反应呈现显著差异(p<0.01)。

核心结论

  • 所开发的GCA-PROMs问卷是评估巨细胞动脉炎患者的可靠且有效的工具。
  • 根据患者个体风险因素、偏好及相关合并症制定分层治疗方案是实现个体化患者管理的最佳方法。

研究设计与样本

  • 基于OMERACT制定的大血管炎核心结局指标框架和FDA指南原则构建GCA-PROMs问卷。
  • 通过认知访谈确定问题条目池,由患者及跨学科专家小组完成条目筛选与精简。
  • 采用Rasch分析和内部一致性信度分析进行验证,共54例GCA患者完成问卷。

主要发现

  • GCA-PROMs问卷标准化α信度为0.878-0.983,显示高信度。
  • GCA-PROMs功能残疾和生活质量的内容结构评估与HAQ和EQ-5D均呈显著相关(p<0.01)。
  • 功能残疾和生活质量的变化随疾病活动状态及治疗反应呈现显著差异(p<0.01)。

关键数值与推荐

  • 标准化α信度范围为0.878-0.983。
  • GCA-PROMs功能残疾和生活质量与HAQ和EQ-5D的相关性p<0.01。
  • 功能残疾和生活质量随疾病活动状态和治疗反应的变化p<0.01。

临床怎么用

  • 原文结论未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Giant Cell Arteritis (GCA) is the commonest form of systemic vasculitis in people over the age of 50. Published research highlighted the lack of a disease-specific patient reported outcomes (PROMs) for GCA. OBJECTIVES: To assess the validity, reliability and responsiveness to change of a devised disease specific patient self-reported outcome measures questionnaire for Giant Cell Arteritis (GCA). METHODS: The GCA-PROMs was conceptualized based on frameworks outlined in the OMERACT developed core set of Outcome Measures for Large-Vessel Vasculitis and the guiding principles of the FDA guidance. Initially, cognitive interviews were conducted to identify item pool of questions. Item selection and reduction was achieved based on patients as well as an interdisciplinary group of specialists. Rasch and internal consistency reliability analyses were implemented. RESULTS: A total of 54 GCA patients completed the questionnaire. The GCA-PROMs questionnaire was reliable as demonstrated by a high standardized alpha (0.878-0.983). Content construct assessment of the GCA-PROMs functional disability and QoL revealed significant correlation (p< 0.01) with both HAQ and EQ-5D. Changes in functional disability, QoL showed significant (p< 0.01) variation with diseases activity status in response to therapy. CONCLUSIONS: The developed GCA-PROMs questionnaire is a reliable and valid instrument for assessment of GCA patients. A stratified treatment regimen depending on the individual patient's risk factors as well as preferences and associated comorbidities is the best approach to tailored patient management.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. El Miedany Y, El Gaafary M, Toth M, et al. Beyond the symptoms: Personalizing giant cell arteritis care through multidimensional patient reported outcome measure. Semin Arthritis Rheum. 2023. PMID: 37944298. doi:10.1016/j.semarthrit.2023.152285

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。